Scientific issues relevant to setting regulatory criteria to identify endocrine-disrupting substances in the european union

Environmental Health Perspectives

Volumn 124, Issue 10, 2016, Pages 1497-1503

  Slama, Rémy ^a   Bourguignon, Jean Pierre ^b   Demeneix, Barbara ^c   Ivell, Richard ^d,e   Panzica, Giancarlo ^f   Kortenkamp, Andreas ^g   Zoeller, R Thomas ^h  

^a UNIV GRENOBLE ALPES   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f UNIVERSITY OF TURIN   (Italy)

^g BRUNEL UNIVERSITY   (United Kingdom)

^h UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCIDE; COSMETIC; ENDOCRINE DISRUPTOR; INDUSTRIAL CHEMICAL; MUTAGENIC AGENT; PESTICIDE;

CONGENITAL MALFORMATION; DANGEROUS GOODS; DOSE RESPONSE; EC50; ENDOCRINE SYSTEM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL PROTECTION; EUROPEAN UNION; GOVERNMENT REGULATION; HAZARD ASSESSMENT; HUMAN; LIFESPAN; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REPRODUCTION; RISK MANAGEMENT; WORLD HEALTH ORGANIZATION;

EID: 84989328967     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/EHP217     Document Type: Note

References (43)

1. Bergman Å, Heindel JJ, Jobling S, Kidd KA, Zoeller RT, eds. 2013. State of the Science of Endocrine Disrupting Chemicals Geneva:World Health Organization. United Nation Environmental Program. Available: http://www.who.int/ceh/publications/endocrine/en/ [accessed 23 March 2016].
2. Braun JM, Kalkbrenner AE, Calafat AM, Yolton K, Ye X, Dietrich KN, et al. 2011. Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics 128:873–882.
3. CEFIC (European Chemical Industry Council). 2013. CEFIC’s Response - Addressing the Four Discussion Topics Included in: the Community Strategy for Endocrine Disruptors. Available: http:// www.asktheeu.org/fr/request/650/response/3056/attach/18/19.sanco.ddg2.e.3%202013%20 2884470%20annex.pdf [accessed 3 April 2016].
4. Colborn T, vom Saal FS, Soto AM. 1993. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378–384.
5. Delfosse V, Maire AL, Balaguer P, Bourguet W. 2014. A structural perspective on nuclear receptors as targets of environmental compounds. Acta Pharmacol Sin, http://dx.doi.org/10.1038/aps.2014.133.
6. Dietrich DR, Aulock Sv, Marquardt H, Blaauboer B, Dekant W, Kehrer J, et al. 2013. Scientifically unfounded precaution drives European Commission’s recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. Chem Biol Interact 205:A1–A5.
7. EFSA (European Food Safety Authority) Scientific Committee. 2013. Scientific opinion on the hazard assessment of endocrine disruptors: scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment. EFSA J 11:3132, doi: 10.2903/j.efsa.2013.3132.
8. European Commission. 1999. Community Strategy for Endocrine Disruptors—a Range of Substances Suspected of Interfering with the Hormone Systems of Humans and Wildlife. Fed Reg COM (1999) 706. Available: http://eur-lex.europa.eu/ legal-content/EN/TXT/?uri=CELEX:51999DC0706 [accessed 3 April 2016].
9. European Commission. 2013. Minutes of the expert meeting on endocrine disruptors. Date: 24/10/2013, 14:00-17:00. Venue: Office of the Chief Scientific Adviser, European Commission, Berlaymont Building, Brussels. Available: http://ec.europa.eu/ archives/commission_2010-2014/president/chief-scientific-adviser/documents/minutes_endocrine_disruptors_meeting_241013_final.pdf [accessed 23 March 2016].
10. European Commission. 2014. Roadmap. Defining Criteria for Identifying Endocrine Disruptors in the Context of the Implementation of the Plant Protection Product Regulation and Biocidal Products Regulation. Available: http://ec.europa.eu/smart-regulation/ impact/planned_ia/docs/2014_env_009_endocrine_disruptors_en.pdf[accessed 3 April 2016].
11. European Commission. 2015. Report on Public Consultation on Defining Criteria for Identifying Endocrine Disruptors in the Context of the Implementation of the Plant Protection Product Regulation and Biocidal Products Regulation. Brussels, Belgium:European Commission, Health and Food Safety. Available: http://ec.europa.eu/ health/endocrine_disruptors/docs/2015_public_consultation_report_en.pdf [accessed 23 March 2016].
12. European Commission. 2016. Communication from the Commission to the European Parliament and the Council on Endocrine Disruptors and the Draft Commission Acts Setting out Scientific Criteria for Their Determination in the Context of the EU Legislation on Plant Protection Products and Biocidal Products. Available: http://ec.europa.eu/ health/endocrine_disruptors/docs/com_2016_350_ en.pdf [accessed 17 August 2016]
13. European Court of Justice. 2015. Règlement (UE) n°528/2012 – Produits biocides – Recours en carence – Spécification des critères scientifiques pour la détermination des propriétés perturbant le système endocrinien – Défaut de la part de la Commission d’adopter des actes délégués – Obligation d’agir [in French]. Available: http://curia. europa.eu/juris/document/document_print.jsf?doclang=FR&text=&pageIndex=0&part=1&mode​ =lst&docid=173067&occ=first&dir=&cid=750233 [accessed 23 March 2016].
14. European Crop Protection Association. 2014. ECPA’s Position on the Criteria for the Determination of Endocrine Disrupting Properties under Regulation 1107/2009. Available: https://www.ecpa.eu/ sites/default/files/23734_ECPA%20position%20 paper%20on%20criteria%20for%20endocrine%20 disrupting%20properties%20-%20updated%20 9%20June%202016.pdf [accessed 23 March 2016].
15. European Parliament. 2000. Directive 2000/60/EC of the European Parliament and of the Council of 23 October 2000 Establishing a Framework for the Community Action in the Field of Water Policy. Available: http://eur-lex.europa.eu/resource.html?uri=cellar:5c835afb-2ec6-4577-bdf8-756d3d694eeb.0004.02/DOC_1&format=PDF [accessed 23 March 2016].
16. European Parliament. 2006. Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Available: https:// echa.europa.eu/regulations/reach/legislation [accessed 23 March 2016].
17. European Parliament. 2008. Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on Classification, Labelling and Packaging of Substances and Mixtures, Amending and Repealing Directives 67/548/EEC and 1999/45/EC, and Amending Regulation (EC) No 1907/2006. Fed Reg No 1272/2008. Available: http://eur-lex.europa.eu/ legal-content/EN/TXT/PDF/?uri=CELEX:32008R1272 &from=EN [accessed 23 March 2016].
18. European Parliament. 2009a. Regulation (EC) No 1107/2009 of 21 October 2009 concerning the Placing of Plant Protection Products on the Market and Repealing Council Directives 79/117/ EEC and 91/414/EEC. Available: http://eur-lex. europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:200 9:309:0001:0050:en:PDF [accessed 23 March 2016].
19. European Parliament. 2009b. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. Available: http://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02009R1223-20150416&from=EN [accessed 23 March 2016].
20. European Parliament. 2012. Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products. Available: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02012R0528-20140425&from=EN [accessed 23 March 2016].
21. Frye CA, Bo E, Calamandrei G, Calzà L, Dessì-Fulgheri F, Fernández M, et al. 2012. Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems. J Neuroendocrinol 24:144–159.
22. Gore AC, Balthazart J, Bikle D, Carpenter DO, Crews D, Czernichow P, et al. 2013. Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology 154:3957–3960.
23. Grandjean P, Ozonoff D. 2013. Transparency and translation of science in a modern world. Environ Health 12:70, doi: 10.1186/1476-069X-12-70.
24. Heindel JJ, vom Saal FS, Blumberg B, Bovolin P, Calamandrei G, Ceresini G, et al. 2015. Parma consensus statement on metabolic disruptors. Environ Health 14:54, doi: 10.1186/s12940-015-0042-7.
25. Hennes C, Batke M, Bomann W, Duhayon S, Kosemund K, Politano V, et al. 2014. Incorporating potency into EU classification for carcinogenicity and reproductive toxicity. Regul Toxicol Pharmacol 70:457–467.
26. IPCS (International Programme on Chemical Safety). 2009. Principles and Methods for the Risk Assessment of Chemicals in Food. Environmental Health Criteria 240. Available: http://www.inchem. org/documents/ehc/ehc/ehc240_index.htm [accessed 23 March 2016].
27. Jacobson JL, Jacobson SW. 1996. Dose-response in perinatal exposure to polychlorinated biphenyls (PCBs): the Michigan and North Carolina cohort studies. Toxicol Ind Health 12:435–445.
28. Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray LE, Kaattari S, et al. 1996. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect 104(suppl 4):715–740.
29. Kortenkamp A, Bourguignon JP, Slama R, Bergman A, Demeneix B, Ivell R, et al. 2016. EU regulation of endocrine disruptors: a missed opportunity. Lancet Diabetes Endocrinology 4:649–650. Available: http:// dx.doi.org/10.1016/ S2213-8587(16)30151-6.
30. Kortenkamp A, Martin O, Faust M, Evans R, McKinlay R, Orton F, et al. 2011. State of the Art of Assessment of Endocrine Disrupters. Final Report. Available: http://ec.europa.eu/environment/chemicals/ endocrine/pdf/sota_edc_final_report.pdf [accessed 23 March 2016].
31. Marx-Stoelting P, Braeuning A, Buhrke T, Lampen A, Niemann L, Oelgeschlaeger M, et al. 2015. Application of omics data in regulatory toxicology: report of an international BfR expert workshop. Arch Toxicol 89:2177–2184.
32. Neubig RR, Spedding M, Kenakin T, Christopoulos A, International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. 2003. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev 55:597–606.
33. Pearce N, Blair A, Vineis P, Ahrens W, Andersen A, Anto JM, et al. 2015. IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect 123:507–514, doi: 10.1289/ehp.1409149.
34. Schantz SL, Widholm JJ, Rice DC. 2003. Effects of PCB exposure on neuropsychological function in children. Environ Health Perspect 111:357–376, doi: 10.1289/ehp.5461.
35. Shelton JF, Geraghty EM, Tancredi DJ, Delwiche LD, Schmidt RJ, Ritz B, et al. 2014. Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE study. Environ Health Perspect 122:1103–1109, doi: 10.1289/ ehp.1307044.
36. Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, et al. 2015. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab 100:1245–1255.
37. U.S. EPA (U.S. Environmental Protection Agency). 2015. What is Endocrine Disruption? Available: https://www.epa.gov/endocrine-disruption/what-endocrine-disruption [accessed 3 April 2016].
38. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, et al. 2012. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33:378–455.
39. Warner M, Wesselink A, Harley KG, Bradman A, Kogut K, Eskenazi B. 2014. Prenatal exposure to dichlorodiphenyltrichloroethane and obesity at 9 years of age in the CHAMACOS study cohort. Am J Epidemiol 179:1312–1322.
40. WHO (World Health Organization). 2014. WHO Expert Meeting: Methods and Tools for Assessing the Health Risks of Air Pollution Local, National and International Level. Cogenhagen, Denmark:WHO Regional Office for Europe. Available: http://www.euro.who.int/en/ health-topics/environment-and-health/air-quality/ publications/2014/who-expert-meeting-methods-and-tools-for-assessing-the-health-risks-of-air-pollution-at-local,-national-and-international-level [accessed 23 March 2016].
41. WHO/IPCS (WHO, International Programme on Chemical Safety). 2002. Global Assessment of the State-of-the-Science of Endocrine Disruptors. WHO/PCS/EDC/02.2. Available: http://www.who. int/ipcs/publications/new_issues/endocrine_ disruptors/en/ [accessed 23 March 2016].
42. WHO/IPCS. 2009. Principles and Methods for the Risk Assessment of Chemicals in Food. Environmental Health Criteria 240. Available: http://www.who. int/foodsafety/publications/chemical-food/en/ [accessed 23 March 2016].
43. Woodruff TJ, Zota AR, Schwartz JM. 2011. Environmental chemicals in pregnant women in the United States: NHANES 2003–2004. Environ Health Perspect 119:878–885, doi: 10.1289/ehp.1002727.